Kestra Medical Technologies, Ltd. KMTS 深 沪
已收盘 12-12 16:00:00 美东时间
26.17
+1.260
+5.06%
华盛通- 最 高27.18
- 今 开26.45
- 成交量 41.46万股
- 最 低 24.32
- 昨 收 24.91
- 总市值 13.46亿
- 52周最高 29.9999
- 市盈率 静 --
- 换手率 0.81%
- 52周最低 13.25
- 委 比 -90.56%
- 总股本 5144.91万
- 历史最高 29.9999
- 量 比 1.40
- 振 幅 11.48%
- 历史最低 13.25
- 每 手 1
- 风险率 3.95%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多电话会总结 ｜ Kestra Medical(KMTS)2026财年Q2业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Kestra Medical业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** 第二季度总营收达到2,260万美元，同比增长53%，主要由Assure系统处方量同比增长54%驱动。 **盈利能力：** 毛利率达到50.6%，较去年同期的39.6%提升11个百分点，这是公司历史上首次突破50%毛利率，实现连续第八个季度的环比改善。 **亏损情况：** GAAP净亏损为3,280万美元，较去年同期的2,060万美元扩大；调整后EBITDA亏损为1,970万美元，较去年同期的1,610万美元增加。 **现金状况：** 截至2
12-12 12:03
Kestra Medical Technologies shares are trading lower after the company reported mixed Q2 financial results.
Kestra Medical Technologies shares are trading lower after the company reported...
12-12 05:23
Kestra Medical Techs FY2026 Revenue expected $91.000M vs $88.138M Est
Kestra Medical Techs (NASDAQ:KMTS) FY2026 Revenue expected to be more than $91.000M vs $88.138M Est
12-12 05:03
Kestra Medical Techs Q2 EPS $(0.64) Misses $(0.59) Estimate, Sales $22.565M Beat $20.704M Estimate
Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.59) by 8.11 percent. The company reported quarterly sales of $22.565 million which
12-12 05:02
Earnings Scheduled For December 11, 2025
Companies Reporting Before The Bell • Hooker Furnishings (NASDAQ:HOFT) is estim...
12-11 19:11
Kestra Medical Technologies shares are trading lower after the company announced an offering of 5.5 million common shares. Also, the company reported preliminary Q2 results.
Kestra Medical Technologies shares are trading lower after the company announce...
12-02 00:23
Kestra Medical Technologies Reports Preliminary Q2 FY26 Revenue Of $22.2M To $22.6M And Gross Profit Of $11M To $11.4M
Cash and cash equivalents are expected to be approximately $175 million.
12-01 20:08
美股大行评级 | Stifel上调英伟达目标价升至250美元；大摩上调哔哩哔哩目标价升至27美元；NICE遭多家机构下调目标价
今日重点评级关注：Oppenheimer：维持Olema Pharmaceuticals"跑赢大市"评级，目标价从22美元升至45美元；Bernstein：维持Atlassian"跑赢大市"评级，目标价从290美元升至304美元
11-19 11:01
BTIG Initiates Coverage On Kestra Medical Techs with Buy Rating, Announces Price Target of $32
BTIG analyst Marie Thibault initiates coverage on Kestra Medical Techs (NASDAQ:KMTS) with a Buy rating and announces Price Target of $32.
11-18 19:35
Kestra Medical Technologies Announces A Late-Breaking Presentation On November 10 Highlighting Primary Results From Its Ace-PAS Trial Of A Next-Generation Wearable Cardioverter Defibrillator System
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), a wearable medical device and digital healthcare company, today announced its participation in the American Heart Association (AHA) Scientific Sessions 2025, to be held
11-04 21:08
